Ligandrol
LGD-4033 – 10mg (2 clicks)
130 clicks/bottle
1 click/5mg
🧬 Selective Androgen Receptor Modulator (SARM)
💊 Oral Capsule | Research Compound
Description
Ligandrol (LGD-4033) is a potent, non-steroidal Selective Androgen Receptor Modulator designed to promote lean muscle mass, strength development, and bone density support through selective activation of androgen receptors in anabolic tissues.
🧪 Form and Storage
– 💊 Form: Oral capsules or liquid solution in sealed container
– 🧊 Storage: Store at 15–25°C, protected from moisture and light
– 🕒 Stability: Stable at controlled room temperature
– ⚠️ Keep container tightly sealed
– 🔁 Designed for once-daily dosing due to extended half-life (~24–36 hrs)
🔬 What is Ligandrol?
Ligandrol (LGD-4033) is a next-generation SARM developed to selectively bind to androgen receptors (AR) in skeletal muscle and bone tissue while minimizing activity in androgen-sensitive organs such as the prostate.
By activating AR pathways, Ligandrol enhances protein synthesis, nitrogen retention, and muscle fiber hypertrophy. It was originally investigated for the treatment of muscle wasting disorders, osteoporosis, and age-related sarcopenia.
Despite promising early research data, LGD-4033 remains an experimental compound and is not approved for medical use.
✅ Benefits of Ligandrol
● Promotes significant lean muscle mass gains
● Enhances strength and power output
● Supports bone mineral density
● Improves nitrogen retention and recovery capacity
● May assist in body recomposition phases
● Exhibits high anabolic-to-androgenic selectivity ratio
● Potential therapeutic relevance in cachexia and frailty research
⚠️ Possible Side Effects
● Dose-dependent testosterone suppression
● Alterations in lipid profile (HDL reduction)
● Possible mild water retention
● Headaches or fatigue in some users
● Limited long-term human safety data
● Experimental status — not FDA approved
📏 Dosage Guidelines (Research Context)
● Research dosage: 5–10 mg per day
● Cycle duration: 6–8 weeks
● Route of administration: Oral
● Post-cycle hormonal recovery protocols may be required due to suppression risk
🧼 Best Practices
● Maintain consistent once-daily dosing schedule
● Conduct baseline and post-cycle blood work
● Monitor lipid panel and testosterone levels
● Avoid stacking with other suppressive agents without monitoring
● Discontinue use if adverse markers emerge
🧠 Lifestyle and Dietary Considerations
● Maintain a high-protein intake (1.6–2.2 g/kg bodyweight)
● Follow structured progressive resistance training
● Prioritize 7–9 hours of sleep for hormonal regulation
● Support cardiovascular health with omega-3 fatty acids
● Avoid excessive alcohol and processed food consumption
💡 Ligandrol (LGD-4033) is a high-affinity SARM designed for anabolic selectivity in muscle and bone tissue research.
Structured monitoring and responsible research application are essential due to its suppressive potential.
